Clinical Trial Update: Dapiglutide for the Treatment of Obesity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for dapiglutide in obesity; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Obesity

Drugs mentioned

• Dapiglutide (dapiglutide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Obesity, Inflammation | Phase 2 | Status: ACTIVE_NOT_RECRUITING